A cDNA library transfer system based on retroviral vectors has been developed for expression cloning in mammalian cells. The use of retroviral vectors results in stable cDNA transfer efficiencies which are at least 100-fold higher than those achieved by transfection and therefore enables the transfer and functional screening of very large libraries. In our initial application of retroviral transfer of cDNA libraries, we have selected for cDNAs which induce oncogenic transformation of NIH 3T3 fibroblasts, as measured by loss of contact inhibition of proliferation. Nineteen different transforming cDNAs were isolated from a total of 300,000 transferred cDNA clones. Three of these cDNAs were derived from known oncogenes (raf-1, lck, and ect2), while nine others were derived from genes which had been cloned previously but were not known to have the ability to transform fibroblasts (-catenin, thrombin receptor, phospholipase C-␥ 2 and Spi-2 protease inhibitor genes). The Spi-2 cDNA was expressed in antisense orientation and therefore is likely to act as an inhibitor of an endogenous transformation suppressor. Seven novel cDNAs with transforming activities, including those for three new members of the CDC24 family of guanine nucleotide exchange factors, were also cloned from the retroviral cDNA libraries. Retroviral transfer of libraries should be generally useful for cloning cDNAs which confer selectable phenotypes on many different types of mammalian cells.Cellular oncogenes or proto-oncogenes can be cloned by selecting for their ability to confer the phenotype of deregulated growth on cells in which they are expressed. This was first done by transfecting fragmented genomic DNA into cell lines such as NIH 3T3 fibroblasts which are susceptible to single-hit oncogenic transformation (13,15,31,36,40,46). Subsequently, stable transfection of these cells with cDNA libraries in plasmid or phage expression vectors has been used as an alternative approach, to avoid the severe difficulties which have been encountered in recovering and analyzing oncogenes present in transfected genomic DNA (8,9,[32][33][34]. Despite the theoretical advantages of working with transfected cDNA expression libraries, only a small fraction of the many currently known oncogenes have been cloned in this way. The most significant limitation in the use of cDNA library transfer for cloning oncogenes has been the low efficiencies of cDNA transfer and expression which can be achieved by stable transfection methods. It is difficult to generate more than a few tens of thousands of transfectants in which cDNA clones are being expressed at adequate levels, but a comprehensive screening of a mammalian cDNA library demands the transfer and expression of several million clones. Therefore, the small number of oncogenes which have been cloned so far from transferred libraries is unlikely to be due to exhaustion of the pool of cDNAs with oncogenic potential but rather is a result of a failure to transfer, and thus detect, most such cDNAs.In contrast to deliberatel...